Encinosa, William - In: Applied Health Economics and Health Policy 7 (2009) 3, pp. 149-154
Drug benefits have responded to the rise in drug costs by increasing patient cost sharing. However, many now realize that increasing cost sharing for high-value preventive-care drugs can be detrimental in terms of reducing patient drug adherence and causing increased inpatient and outpatient...